Search results for: 'denali captura scienc 2017'
- Did you mean
- deal captura scienc 2017
- Related search terms
- denali and alliance
- 2017 deaf alliance review
- 2017 del alliance review
- scienc+cross+partnering+221b+221b
- 2017 duke alliance review
-
Licensing Deals in Pharmaceuticals 2019-2024September 2024$3,995.00
Licensing Deals in Pharmaceuticals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2024
Learn More -
Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024August 2024$3,995.00
The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024 report provides comprehensive understanding and unprecedented access to the discovery stage partnering agreements entered into by the world's leading biopharma companies.
Learn More -
Global Academic and Non-Profit Partnering Terms and Agreements 2019-2024October 2024$3,995.00
Global Academic and Non-Profit Partnering Terms and Agreements 2019-2024 report provides a detailed understanding and analysis of how and why companies enter Academic and Non-Profit partnering deals.
Learn More -
Biomarker Collaboration and Licensing Deals 2016-2024November 2024$3,995.00
Biomarker Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024September 2024$3,995.00
Joint Venture Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Respiratory Collaboration and Licensing Deals 2016-2024October 2024$3,995.00
Respiratory Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2016 to 2024
Learn More -
Vaccine Collaboration and Licensing Deals 2016-2024November 2024$3,995.00
Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Infectious Diseases Collaboration and Licensing Deals 2019-2024October 2024$3,995.00
Infectious Diseases Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024
Learn More -
Distribution Deals in Pharmaceuticals and Biotechnology 2016-2024September 2024$3,995.00
Distribution Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Asset Purchase Deals in Pharmaceuticals, Biotechnology, Medical Devices and Diagnostics 2016 to 2024September 2024$3,995.00
Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More